Not Yet Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm
NCT06981338
Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation (GNR-SCI-01)
Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation: A Pilot Study
Sponsor: Institut Guttmann
Conditions
Spinal Cord Disease Spinal Cord Injuries (SCI) Spinal Cord Injury Traumatic Spinal Cord Injuries
Updated 1 time since 2025 Last updated: May 21, 2025 Started: Sep 1, 2025 Primary completion: Mar 1, 2026 Completion: Dec 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06981338, this PHASE1/PHASE2 trial focuses on Spinal Cord Disease and Spinal Cord Injuries (SCI) and remains actively recruiting participants. Sponsored by Institut Guttmann, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Institut Guttmann
Data source: Institut Guttmann
For direct contact, visit the study record on ClinicalTrials.gov .